Evidence map›Paper›PMID 42478819›Full record

ArticleApplied and environmental microbiology2026

Extracellular metabolite production by

Yi-Hsuan Lee, Verena Siewers, Johan Larsbrink

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yi-Hsuan LeeDivision of Industrial Biotechnology, Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
Verena SiewersDivision of Systems and Synthetic Biology, Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.ORCID 0000-0002-9502-9804
Johan LarsbrinkDivision of Industrial Biotechnology, Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.ORCID 0000-0001-8386-2914

Funding

Swedish Research Council for Sustainable Development (FORMAS) 2021-01079
6 · The paper itself

Abstract

The microorganisms comprising the gut microbiota perform various important functions, such as producing short-chain fatty acids (SCFAs) and other metabolites that can be taken up by the host and used as energy sources or as signaling molecules. A major nutrient for the microbiota is dietary fiber, mainly composed of complex polysaccharides that cannot be degraded by host enzymes. Species from the Bacteroidota phylum are regarded as proficient carbohydrate degraders, partly thanks to their multi-gene systems, known as polysaccharide utilization loci (PULs), encoding the necessary proteins for carbohydrate capture and cleavage. Linking which species can grow on which polysaccharides, depending on the presence of corresponding PULs encoded in their genomes, has been studied intensely in the last decades. However, little is known about which metabolites they produce from carbohydrate consumption, as previous investigations have mainly used glucose as the sole carbon source. In this study, we grew several Bacteroidota species on different carbohydrates, from monosaccharides to polysaccharides, and quantified the resulting extracellular metabolites produced. The results reveal different extracellular metabolite profiles, both intraspecies and interspecies, depending on the carbon sources. Surprisingly, in some cases, the production of extracellular metabolites differed between growth on a homopolysaccharide and its constituent monosaccharide. The results indicate that the metabolite output of gut species is not static but varies with the nutrients present, adding to the complexity of the interplay among dietary fiber, microbial ecology, and gut health. IMPORTANCE: The human gut microbiota is closely linked to health, and metabolism of different types of dietary fibers is a core activity within this community. Many studies have investigated the composition of the microbiota and sought to relate the presence and abundance of species to health or disease, often attributing a genus or species to consumption or production of a certain metabolite to explain an overall phenotype. It is known that bacteria have different carbohydrate-degrading abilities, but they may not produce a static output of metabolites from the consumption of different carbohydrates, from monosaccharides to complex polysaccharides. This study demonstrates that common bacteria in the

Indexed as

BacteroidesCarbohydrate MetabolismCarbonGastrointestinal MicrobiomeCarbonBacteroidesBacteroides thetaiotaomicroncarbohydrate utilizationgut microbiotaSCFAshort-chain fatty acid

Identifiers

PMID42478819
PMCPMC13488361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.